Diabetology - Diabetology Xagena

Diabetology

News

Drugs

Xagena Medicine

Xagena.net

Diabetes mellitus: Onglyza added to Insulin improves glycosylated hemoglobin levels compared to placebo added to Insulin

2011 - Rheumatoid arthritis and psoriasis patients: Hydroxychloroquine and TNF inhibitors linked to reduced risk for the development of diabetes mellitus

Lifestyle intervention provides benefits for overweight patients with type 2 diabetes

Primary prevention in moderate and high risk diabetics: Acetylsalicylic acid

Diabetes mellitus in elderly patients: severe hypoglycemia linked with higher risk of dementia

Atrial fibrillation linked to an increased risk of death in patients with diabetes mellitus

Diabetes mellitus: better glycemic control with Liraglutide compared to Exenatide

Increased risk for atrial fibrillation in women with diabetes mellitus

Gestational diabetes mellitus: sugary cola drinks linked to higher risk

Lung carcinoma associated with Exubera

Increased risk of fractures due to Pioglitazone and Rosiglitazone in women with type 2 diabetes mellitus

Diabetes mellitus: management

Advances in islet cell transplants in diabetes patients

Glivec and Sutent prevent and reverse type 1 diabetes in mouse model

Slower progression of diabetic retinopathy with Avandia

Actos and Avandia in diabetes carry different risks of heart failure and mortality

Possible positive cardiovascular effects with antidiabetic drug Metformin

Cardiovascular risks with thiazolidinediones in diabetes mellitus

Type 1 diabetes: prevention and remission with the use of Glivec and Sutent

Dabetes drugs: thiazolidinediones carries significant cardiovascular risks

Imatinib and Sunitinib prevent, reverse type 1 diabetes in murine model

Diabetes: promising advances in islet cell transplants

Diabetes: no convincing evidence that thiazolidinediones work better than older drugs

Diabetes mellitus of type 2: Actos and Avandia may be related to fracture risk

Risk of cardiovascular events: Pioglitazone appears to have overall favorable effect

Women with high blood pressure are up to three times more likely to develop diabetes mellitus

Onglyza added to Metformin improves glycemic control compared to Metformin alone in type 2 diabetes

Antibody therapy prevents type 1 diabetes in mouse model

The benefit-risk ratio of Avandia is not defined

Carnosinase 1 gene associated with severe kidney failure in diabetes

Next Pages [1] 2 3 4

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Pulmonology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions